 CHATHAM, N.J., Oct. 31, 2022 GLOBE NEWSWIRE -- Tonix Pharmaceuticals Holding Corp. Nasdaq: TNXP, a clinical-stage biopharmaceutical company, announced today that Jessica Morris, Chief Operating Officer of Tonix Pharmaceuticals, will present at BioFuture on Tuesday, November 8, 2022, at 11:00 a.m. ET, and host investor meetings. The conference is being held at the Lotte New York Palace in New York City. 